Second-Line Treatment of Advanced Non-small Cell Lung Cancer

After failure of first-line chemotherapy for advanced non-small cell lung cancer, many patients remain candidates to receive further antitumor treatment. To guide clinical management of these patients and to suggest priorities for clinical research, an International Panel of Experts met in Naples (I...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of thoracic oncology 2008-04, Vol.3 (4), p.430-440
Hauptverfasser:	Gridelli, Cesare, Ardizzoni, Andrea, Ciardiello, Fortunato, Hanna, Nasser, Heymach, John V., Perrone, Francesco, Rosell, Rafael, Shepherd, Frances A., Thatcher, Nick, Vansteenkiste, Johan, De Petris, Luigi, Di Maio, Massimo, De Marinis, Filippo
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - secondary Docetaxel Erlotinib Erlotinib Hydrochloride Glutamates - administration & dosage Guanine - administration & dosage Guanine - analogs & derivatives Humans Lung Neoplasms - drug therapy Lung Neoplasms - pathology Non-small cell lung cancer Pemetrexed Practice Guidelines as Topic Practice Patterns, Physicians Prognosis Quinazolines - administration & dosage Quinazolines - antagonists & inhibitors Randomized Controlled Trials as Topic Retrospective Studies Salvage Therapy Second-line chemotherapy Survival Rate Taxoids - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!